Anticancer and radio-sensitizing evaluation of some new sulfonamide derivatives bearing pyridone, thiophene, and hydrazone moieties
- 15 February 2017
- journal article
- research article
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 43 (8) , 4657-4681
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- State-of-the-art of small molecule inhibitors of the TAM family: The point of view of the chemistEuropean Journal of Medicinal Chemistry, 2015
- Design, synthesis and anticancer activity of new 3-cyano-2 (1H) -pyridone and 3-cyanopyridine-2-(1H)-thione DerivativesOriental Journal of Chemistry, 2015
- Inactivation of Cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a Thiophene-Containing Anticancer DrugDrug Metabolism and Disposition, 2011
- Biological Activities of Hydrazone DerivativesMolecules, 2007
- Discovery of a novel small molecule binding site of human survivinBioorganic & Medicinal Chemistry Letters, 2007
- Identification and structure–activity relationships of substituted pyridones as inhibitors of Pim-1 kinaseBioorganic & Medicinal Chemistry Letters, 2007
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluationBioorganic & Medicinal Chemistry Letters, 2003
- Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agentsJournal of Medicinal Chemistry, 1988
- Fredericamycin A a new antitumor antibiotic. I. Production, isolation and physicochemical properties.The Journal of Antibiotics, 1981